
ESMO Congress 2026
October 23–27, 2026 · Madrid · 176 items
durvalumab
0 people · 0 posts
Floor
clinicaltrials.govScore3434
JAMA OncologyScore5252 Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer
durvalumabNo engagement yet
x.com@Score6060 Shattering resistance in resectable NSCLC!
x.com@Score6060 x.com@Score6060 x.com@Score6060